Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733

Article  CAS  PubMed  PubMed Central  Google Scholar 

https://virological.org/t/novel-2019-coronavirus-genome/319. virological.org. Accessed 1/17/2023.

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Wkly 2:113–122

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yavarian J, Shafiei-Jandaghi NZ, Sadeghi K, Shatizadeh Malekshahi S, Salimi V, Nejati A et al (2020) First cases of SARS-CoV-2 in Iran, 2020: case series report. Iran J Public Health 49:1564–1568

PubMed  PubMed Central  Google Scholar 

Cereda D, Manica M, Tirani M, Rovida F, Demicheli V, Ajelli M et al (2021) The early phase of the COVID-19 epidemic in Lombardy. Italy Epidemics 37:100528

Article  CAS  PubMed  Google Scholar 

Bedford T, Greninger AL, Roychoudhury P, Starita LM, Famulare M, Huang ML et al (2020) Cryptic transmission of SARS-CoV-2 in Washington state. Science 370:571–575

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hernandez MM, Gonzalez-Reiche AS, Alshammary H, Fabre S, Khan Z, van De Guchte A et al (2021) Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave. Nat Commun 12:3463

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skowronski DM, Astell C, Brunham RC, Low DE, Petric M, Roper RL et al (2005) Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 56:357–381

Article  CAS  PubMed  Google Scholar 

Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367:1814–1820

Article  CAS  PubMed  Google Scholar 

Vijgen L, Keyaerts E, Moës E, Thoelen I, Wollants E, Lemey P et al (2005) Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol 79:1595–1604

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menachery VD, Yount BL, Debbink K, Agnihothram S, Gralinski LE, Plante JA et al (2015) A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med 21:1508–1513

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Mendelsohn E, Zong C, Zhang W, Hagan E, Wang N et al (2019) Human-animal interactions and bat coronavirus spillover potential among rural residents in Southern China. Biosaf Health 1:84–90

Article  PubMed  PubMed Central  Google Scholar 

Amanat F, Krammer F (2020) SARS-CoV-2 vaccines: status report. Immunity 52:583–589

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krammer F (2020) SARS-CoV-2 vaccines in development. Nature 586:516–527

Article  CAS  PubMed  Google Scholar 

Pallesen J, Wang N, Corbett KS, Wrapp D, Kirchdoerfer RN, Turner HL et al (2017) Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A 114:E7348–E7357

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL et al (2016) Pre-fusion structure of a human coronavirus spike protein. Nature 531:118–121

Article  CAS  PubMed  PubMed Central  Google Scholar 

Letko M, Marzi A, Munster V (2020) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5:562–569

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX et al (2020) Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 395:1845–1854

Article  CAS  PubMed  PubMed Central  Google Scholar 

Science. https://www.science.org/content/article/russia-s-approval-covid-19-vaccine-less-meets-press-release. Accessed 1/6/2023.

El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ et al (2021) Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. N Engl J Med 385:1774–1785

Article  PubMed  Google Scholar 

Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS et al (2021) Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 398:2093–2100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown CM, Vostok J, Johnson H, Burns M, Gharpure R, Sami S et al (2021) Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings - Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep 70:1059–1062

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sano K, Bhavsar D, Singh G, Floda D, Srivastava K, Gleason C et al (2022) SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals. Nat Commun 13:5135

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huai Luo C, Paul Morris C, Sachithanandham J, Amadi A, Gaston DC, Li M et al (2022) Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant is associated with higher recovery of infectious virus compared to the alpha variant in both unvaccinated and vaccinated individuals. Clin Infect Dis 75:e715–e725

Article  PubMed  Google Scholar 

von Wintersdorff CJH, Dingemans J, van Alphen LB, Wolffs PFG, van der Veer BMJW, Hoebe CJPA et al (2022) Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concern. Sci Rep 12:13922

Article  Google Scholar 

Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, Kimura I et al (2022) Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603:706–714

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W (2022) Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. JAMA Netw Open 5:e2228008

Article  PubMed  PubMed Central  Google Scholar 

Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ et al (2022) Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376:eabn4947

Article  CAS  PubMed  Google Scholar 

Chin ET, Leidner D, Lamson L, Lucas K, Studdert DM, Goldhaber-Fiebert JD et al (2022) Protection against Omicron from Vaccination and Previous Infection in a Prison System. N Engl J Med 387:1770–1782

Article  CAS  PubMed  Google Scholar 

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB et al (2022) Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes. JAMA Netw Open 5:e2232760

Article  PubMed  PubMed Central  Google Scholar 

Crotty S (2021) Hybrid immunity. Science 372:1392–1393

Article  CAS  Google Scholar 

Carreño JM, Alshammary H, Tcheou J, Singh G, Raskin A, Kawabata H et al (2022) Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature 602(7898):682–688. https://doi.org/10.1038/s41586-022-04399-5

Article  CAS  PubMed  Google Scholar 

Björk J, Bonander C, Moghaddassi M, Rasmussen M, Malmqvist U, Inghammar M, et al (2022) COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022. Euro Surveill 27(18). https://doi.org/10.2807/1560-7917.ES.2022.27.18.2200322

Chemaitelly H, Ayoub HH, AlMukdad S, Coyle P, Tang P, Yassine HM et al (2022) Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar. Nat Commun. 13:3082

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tarke A, Coelho CH, Zhang Z, Dan JM, Yu ED, Methot N et al (2022) SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell 185:847–59.e11

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aleman A, Upadhyaya B, Tuballes K, Kappes K, Gleason CR, Beach K et al (2021) Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma. Cancer Cell 39:1442–1444

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Oekelen O, Gleason CR, Agte S, Srivastava K, Beach KF, Aleman A et al (2021) Highly variable SARS-CoV-2 spike antibody respons